Indbro Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 M
as on 06-07-2024
- Revenue 207.71%
(FY 2022)
- Profit 42.91%
(FY 2022)
- Ebitda 40.55%
(FY 2022)
- Net Worth 9.19%
(FY 2022)
- Total Assets 327.25%
(FY 2022)
About Indbro Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hemanth Anumolu and Srinivasa Anumolu serve as directors at the Company.
- CIN/LLPIN
U01229TG2004PTC042492
- Company No.
042492
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Indbro Bio-Tech Private Limited offer?
Indbro Bio-Tech Private Limited offers a wide range of products and services, including Meat & Poultry Food, Egg.
Who are the key members and board of directors at Indbro Bio-Tech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Anumolu  | Managing Director | 24-Jan-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemanth Anumolu | Director | 15-May-2018 | Current |
Financial Performance of Indbro Bio-Tech.
Indbro Bio-Tech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 207.71% increase. The company also saw a substantial improvement in profitability, with a 42.91% increase in profit. The company's net worth moved up by a moderate rise of 9.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indbro Bio-Tech?
In 2022, Indbro Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indbro Research And Breeeding Farms Private LimitedActive 23 years 11 monthsSrinivasa Anumolu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 29 Nov 2004 | ₹4.00 M | Satisfied |
How Many Employees Work at Indbro Bio-Tech?
Unlock and access historical data on people associated with Indbro Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indbro Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indbro Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
